These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1388 related items for PubMed ID: 12879230
1. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years. Grinyó JM, Gil-Vernet S, Cruzado JM, Caldés A, Riera L, Serón D, Rama I, Torras J. Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230 [Abstract] [Full Text] [Related]
2. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft. Grinyó JM, Gil-Vernet S, Seron D, Hueso M, Fulladosa X, Cruzado JM, Moreso F, Fernandez A, Torras J, Riera L, Castelao AM, Alsina J. Nephrol Dial Transplant; 1998 Oct; 13(10):2601-4. PubMed ID: 9794567 [Abstract] [Full Text] [Related]
6. Calcineurin inhibitor-free immunosuppressive strategy in elderly recipients of renal allografts from deceased donors: 1-year results from a prospective single center trial. Arbogast HP, Hoffmann JN, Illner WD, Hillebrand GF, Fischereder M, Jauch KW, Land W. Transplant Proc; 2009 Oct; 41(6):2529-32. PubMed ID: 19715968 [Abstract] [Full Text] [Related]
7. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Sollinger HW. Transplantation; 1995 Aug 15; 60(3):225-32. PubMed ID: 7645033 [Abstract] [Full Text] [Related]
8. Calcineurin-inhibitor avoidance in elderly renal allograft recipients using ATG and basiliximab combined with mycophenolate mofetil. Guba M, Rentsch M, Wimmer CD, Uemueksuez A, Illner WD, Schönermarck U, Land WG, Jauch KW, Arbogast H. Transpl Int; 2008 Jul 15; 21(7):637-45. PubMed ID: 18282242 [Abstract] [Full Text] [Related]
9. Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial. Guba M, Pratschke J, Hugo C, Krämer BK, Nohr-Westphal C, Brockmann J, Andrassy J, Reinke P, Pressmar K, Hakenberg O, Fischereder M, Pascher A, Illner WD, Banas B, Jauch KW, SMART-Study Group. Transplantation; 2010 Jul 27; 90(2):175-83. PubMed ID: 20463641 [Abstract] [Full Text] [Related]
11. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group. Transplantation; 1996 Mar 15; 61(5):722-9. PubMed ID: 8607174 [Abstract] [Full Text] [Related]
12. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol. Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ. Clin Transplant; 2007 Mar 15; 21(1):101-9. PubMed ID: 17302598 [Abstract] [Full Text] [Related]
13. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids. Cantarovich D. J Nephrol; 2004 Mar 15; 17 Suppl 8():S40-6. PubMed ID: 15599885 [Abstract] [Full Text] [Related]
14. CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A. Abou-Ayache R, Büchler M, Lepogamp P, Westeel PF, Le Meur Y, Etienne I, Lobbedez T, Toupance O, Caillard S, Goujon JM, Bergougnoux L, Touchard G. Nephrol Dial Transplant; 2008 Jun 15; 23(6):2024-32. PubMed ID: 18199693 [Abstract] [Full Text] [Related]
15. Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy. Birkeland SA. Transplantation; 1998 Nov 15; 66(9):1207-10. PubMed ID: 9825819 [Abstract] [Full Text] [Related]
16. A calcineurin antagonist-free induction/maintenance strategy for immunosuppression in elderly recipients of renal allografts from elderly cadaver donors: long-term results from a prospective single centre trial. Arbogast H, Hückelheim H, Schneeberger H, Illner WD, Tarabichi A, Fertmann J, Wimmer CD, Hillebrand GF, Mistry-Burchardi N, Thomae R, Acikgöz A, Land W. Clin Transplant; 2005 Jun 15; 19(3):309-15. PubMed ID: 15877790 [Abstract] [Full Text] [Related]
17. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function. Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R. Clin Transplant; 2000 Dec 15; 14(6):550-4. PubMed ID: 11127307 [Abstract] [Full Text] [Related]
20. Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil. Mourad M, Malaise J, Chaib Eddour D, De Meyer M, König J, Schepers R, Squifflet JP, Wallemacq P. Clin Chem; 2001 Jan 15; 47(1):88-94. PubMed ID: 11148182 [Abstract] [Full Text] [Related] Page: [Next] [New Search]